The role of B7 costimulation in T-cell immunity

Immunology and Cell Biology

Volumn 77, Issue 4, 1999, Pages 304-311

  Harris, Nicola L ^a   Ronchese, Franca ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

B7 1; B7 2; CD28; Costimulation; Effector cell; Humoral immunity; Memory cell; Th1 Th2 cell

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL POPULATION; CELLULAR IMMUNITY; EFFECTOR CELL; EOSINOPHIL; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MAST CELL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; HUMANS; IMMUNOCONJUGATES; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0032807417     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00835.x     Document Type: Review

References (98)

1. 1 Freedman AS, Freeman GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 1991; 137: 429-37.
2. 2 Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J. Immunol. 1993; 150: 1286-95.
3. 3 Gross JA, Callas E, Allison JP. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992; 149: 380-8.
4. 4 Gross JA, St John T, Allison JP. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J. Immunol. 1990; 144: 3201-10.
5. 5 Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993; 11: 191-212.
6. 6 Cerdan C, Martin Y, Courcoul M et al. CD28 costimulalion up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. J. Immunol. 1995; 154: 1007-13.
7. 7 Freeman GJ at al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7 1 preferentially costimulatcs the initial production of IL-4. Immunity 1995; 2: 523-32.
8. 8 Cerdan C, Martin Y, Courcoul M et al. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J. Immunol. 1992; 149: 2255-61.
9. 9 Reiser H, Freeman GJ, Razi-Wolf Z et al. Murine B7 antigen provides an efficient costimulaiory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl Acad. Sci. USA 1992; 89: 271-5.
10. 10 Fraser JD, Weiss A. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 1992; 12: 4357-63.
11. 11 Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251: 313-16.
12. 12 Thompson CB, Lindsten T, Ledbetter JA et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 1989; 86: 1333-7.
13. 13 Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokinec messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244: 339-43.
14. 14 Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7 2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262: 909-11.
15. 15 Freeman GJ, Borriello F, Hodes RJ et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993; 262: 907-9.
16. 16 Gimmi CD, Freeman GJ, Gribben JG et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl Acad. Sci. USA 1991; 88: 6575-9.
17. 17 Boise LH, Minn AJ, Noel PJ et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bel-XL. Immunity 1995; 3: 87-98.
18. 18 Linsley PS, Brady W, Urnes M et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991; 174: 561-9.
19. 19 Waterhouse P, Marengere LE, Mittrucker HW, Mak TW. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 1996; 153: 183-207.
20. 20 Freeman GJ, Lombard DB, Gimmi CD et al. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 1992; 149: 3795-801.
21. 21 June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol. Today 1990; 11: 211-16.
22. 22 Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J. Immunol. 1990; 144: 1646-53.
23. 23 Gross JA, Callas E, Allison JP. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992; 149: 380-8.
24. 24 Linsley PS, Greene JL, Tan P et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 1992; 176: 1595-604.
25. 25 June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321-31.
26. 26 Lindsten T, Lee KP, Harris ES et al. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 1993; 151: 3489-99.
27. 27 Lesslauer W, Gmunder H. Biochemical characterization of the 9.3 antigens of human T-cells: Simultaneous expression of disulfide-bonded 90-kilodalton dimers and free subunits at the cell surface. Mol. Immunol. 1986; 23; 271-8.
28. 28 Peach RJ, Bajorath J, Brady W et al. Complementarity determining region 1 (CDR1) - and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 1994; 180: 2049-58.
29. 29 Linsley PS, Greene JL, Brady W et al. Human b7 1 (cd80) and b7-2 (cd86) bind with similar avidities but distinct kinetics to cd28 and ctla-4 receptors. Immunity 1994; 1: 793-801.
30. 30 van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. CD80 (B7 1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 1997; 185: 393-403.
31. 31 Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2: A CTLA-4 counter-receptor that costimulales human T cell proliferation. Science 1993; 262: 909-11.
32. 32 Borriello F, Sethna MP, Boyd SD et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997; 6: 303-13.
33. 33 Peach RJ, Bajorath J, Naemura J et al. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 1995; 270: 21181-7.
34. 34 Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996; 14: 233-58.
35. 35 Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7 2 costimulatory ligands: Expression and function. J. Exp. Med. 1994; 180: 631-40.
36. 36 Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76-9.
37. 37 Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 1994; 180: 1849-60.
38. 38 Lenschow DJ, Sperling AI, Cooke MP et al. Differential up-regulation of the B7 1 and B7 2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 1994; 153: 1990-7.
39. 39 Fleischer J, Soeth F, Reiling N et al. Differential expression and function of CD80 (B7 1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 1996; 89: 592-8.
40. 40 Chang CH, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur. J. Immunol. 1995; 25: 394-8.
41. 41 Nabavi N, Freeman GJ, Gault A et al. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992; 360: 266-8.
42. 42 Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995; 182: 459-65.
43. 43 Boussiotis VA, Freeman GJ, Gribben JG et al. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl Acad. Sci. USA 1993; 90: 11059-63.
44. 44 Lenschow DJ, Su GH, Zuckerman LA et al. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl Acad. Sci. USA 1993; 90: 11054-8.
45. 45 Ho WY, Cooke MP, Goodnow CC, Davis MM. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J. Exp. Med. 1994; 179: 1539-49.
46. 46 Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993; 177: 925-35.
47. 47 Roy M, Aruffo A, Ledbetter J et al. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 1995; 25: 596-603.
48. 48 Tan P, Anasetti C, Hansen JA et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 1993; 177: 165-73.
49. 49 Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607-9.
50. 50 Linsley PS, Wallace PM, Johnson J et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257: 792-5.
51. 51 Lenschow DJ, Zeng Y, Thistlethwaite JR et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig. Science 1992; 257: 789-92.
52. 52 Lin H, Bolling SF, Linsley PS et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 1993; 178: 1801-6.
53. 53 Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994; 265: 1225-7.
54. 54 Perrin PJ, Scott D. Quigley L et al. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 1995; 154: 1481-90.
55. 55 Kawai K, Shahinian A, Mak TW, Ohashi PS. Skin allograft rejection in CD28-deficient mice. Transplantation 1996; 61: 352-5.
56. 56 Green JM, Noel PJ, Sperling AI et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994; 1: 501-8.
57. 57 Shahinian A, Pfeffer K, Lee KP et al. Differential T cell costimulatory requirements in CD28-dcficicnt mice. Science 1993; 261: 609-12.
58. 58 Harris N, Campbell C, Le Gros G, Ronchese F. Blockade of CD28/B7 co-stimulation by mCTLA4-Hgammal inhibits antigen-induced lung eosinophilia but not Th2 cell development or recruitment in the lung. Eur. J. Immunol. 1997; 27: 155-61.
59. 59 Harris NL, Peach RJ, Ronchese F. CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. Eur. J. Immunol. 1999; 29: 311-16.
60. 60 Bachmann MF, McKall-Faienza K, Schmits R et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation. Immunity 1997; 7: 549-57.
61. 61 Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenie stimulation determines the fate of naive and effector T cells. Immunity 1998; 8: 89-95.
62. 62 Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555-9.
63. 63 Allison JP. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 1994; 6: 414-19.
64. 64 Dubey C, Croft M, Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 1996; 157: 3280-9.
65. 65 Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 1994; 152: 2675-85.
66. 66 Croft M, Duncan DD, Swain SL. Response of naive antigen-specific CD4+ T cells in vitro: Characteristics and antigen-presenting cell requirements. J. Exp. Med. 1992; 176: 1431-7.
67. 67 Duncan DD, Swain SL. Role of antigen-presenting cells in the polarized development of helper T cell subsets: Evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 1994; 24: 2506-14.
68. 68 Ronchese F, Hausmann B. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 1993; 177: 679-90.
69. 69 Via CS, Rus V, Nguyen P, Linsley P, Gause WC. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 1996; 157: 4258-67.
70. 70 Gause WC, Lu P, Zhou XD et al. IL polygyrus: B7-independence of the secondary type 2 response. Exp. Parasitol. 1996; 84: 264-73.
71. 71 Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M. B7 CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 1997; 158: 2042-9.
72. 72 Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-57.
73. 73 King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G. CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur. J. Immunol. 1995; 25: 587-95.
74. 74 Rulifson IC, Sperling AI, Fields PH, Fitch FW, Bluestone JA. CD28 costimulalion promotes the production of Th2 cytokines. J. Immunol. 1997; 158: 658-65.
75. 75 Corry DB, Reiner SL, Linsley PS, Locksley RM. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 1994; 153: 4142-8.
76. 76 Lenschow DJ, Herold KC, Rhee L et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes (published erratum appears in Immunity 1997; 6: 215). Immunity 1996; 5: 285-93.
77. 77 Kundig TM, Shahinian A, Kawai K et al. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 1996; 5: 41-52.
78. 78 King CL, Xianli J, June CH, Abe R, Lee KP. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 1996; 26: 2448-55.
79. 79 Lu P, Zhon X, Chen SJ et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 1994; 180: 693-8.
80. 80 Palmer LD, Saha B, Hodes RJ, Abe R. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses. J. Immunol. 1996; 156: 2112-18.
81. 81 Lenschow DJ, Zeng Y, Hathcock KS et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60: 1171-8.
82. 82 Zitvogel L, Mayordomo JI, Tjandrawan T et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 1996; 183: 87-97.
83. 83 McKnight AJ, Perez VL, Shea CM, Gray GS, Abbas AK. Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. J. Immunol. 1994; 152: 5220-5.
84. 84 McArthur JG, Raulet DH. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 1993; 178: 1645-53.
85. 85 Lane P, Burdet C, Hubele S et al. B cell function in mice transgenic for mCTLA4-H gamma 1: Lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med. 1994; 179: 819-30.
86. 86 Ronchese F, Hausmann B, Hubele S, Lane P. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J. Exp. Med. 1994; 179: 809-17.
87. 87 Zimmermann C, Seiler P, Lane P, Zinkernagel RM. Antiviral immune responses in CTLA4 transgenic mice. J. Virol. 1997; 71: 1802-7.
88. 88 Linsley PS, Brady W, Grosmaire L et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 1991; 173: 721-30.
89. 89 Freeman GJ, Borriello F, Hodes RJ et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 1993; 178: 2185-92.
90. 90 Razi-Wolf Z, Freeman GJ, Galvin F et al. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl Acad. Sci. USA 1992; 89: 4210-14.
91. 91 Kuchroo VK, Das MP, Brown JA et al. B7 1 and B7 2 costimulatory molecules activate differentially the Th1-Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995; 80: 707-18.
92. 92 Lanier LL, O'Fallon S, Somoza C et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 1995; 154: 97-105.
93. 93 Anderson DE, Ausubel LJ, Krieger J et al. Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones. J. Immunol. 1997; 159: 1669-75.
94. 94 Lenschow DJ, Ho SC, Saltar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 1995; 181: 1145-55.
95. 95 Levine BL, Ueda Y, Craighead N, Huang ML, June CH. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 1995; 7: 891-904.
96. 96 Miller SD, Vanderlugt CL, Lenschow DJ et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995; 3: 739-45.
97. 97 Windhagen A, Newcombe J, Dangond F et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 1995; 182: 1985-96.
98. 98 Harris N, Peach R, Nacmura J et al. CD80 costimulation is essential for the induction of airway cosinophilia. J. Exp. Med. 1997; 185: 177-82.